Dr Sara Valentini
Genomic Surveillance Business Analyst
Sara obtained her Master’s in Biology in Germany and her PhD in Biology of Ageing at the University College London (UCL). After 10 years in science she switched to research and project management in 2012 when joining Sanger. She expanded her expertise into Business Analysis in 2022. Her scientific and management background combined with her business analysis skills provides a solid and in-depth understanding of operational science and all aspects involved.
Since joining Sanger in 2012 I have been involved in managing large scale programs, such as the Organoid Derivation Project, Cancer Dependency Map and the Genomics of Drug Sensitivity in Cancer (GDSC) cell line screening platform. I’m now working in the Genomic Surveillance Unit as Business Analyst to optimize and implement new genomic surveillance activities for new surveillance programmes of work.
As Business Analyst I am a communication focal point for between multidisciplinary stakeholders in order to:
- Investigate and analyse problems
- Improve business processes
- Define requirements
- Deployment of business change
Genomic Surveillance Business Analyst, Genomic Surveillance Unit
Genomic Surveillance Operations Lead, Genomic Surveillance Unit
Project Manager, Wellcome Sanger Institute
Project Coordinator, Wellcome Sanger Institute
Project Management Assistant, Wellcome Sanger Institute
PhD in Biology of Ageing, University College London (UCL)
Masters Diploma in Biology, University of Technology, Kaiserslatern, Germany